Free signup for more
- Track your favorite companies
- Receive email alerts for new filings
- Personalized dashboard of news and more
- Access all data and search results
Content analysis
?Positive | ||
Negative | ||
Uncertain | ||
Constraining | ||
Legalese | ||
Litigous | ||
Readability |
H.S. freshman Avg
|
New words:
acute, administered, assist, bankruptcy, bifurcation, civil, Code, collaboration, collectively, compound, coordinate, criminal, cumulative, default, Department, documentation, embedded, enforcement, ensuing, environment, EPS, experimental, failure, Fordham, half, HCV, HDV, headcount, inciting, Intelligence, isomerase, Justice, listed, literature, lung, NaN, oversight, owed, ownership, past, pathologic, platelet, Precision, premium, reduction, regression, regulate, repay, replication, SBA, showed, shown, suggest, ThinkEquity, tool, transplant, underwritten, wholly
Removed:
accelerated, advantage, advisory, aforementioned, agent, agreed, analyze, anniversary, applied, assurance, attain, billion, cease, certificate, clarifying, commercially, complying, contemplated, correspondingly, declared, demonstrating, difficult, DNA, doubt, examine, exceeded, exemption, FBR, File, filer, fully, golden, HBeAg, HBsAg, immunity, impose, incorporation, innate, irrevocably, Jumpstart, justify, legislation, lieu, monitor, Nasdaq, NTCP, obtain, ordinary, parachute, parent, participation, party, PK, play, pleiotropic, proportion, prospectively, Recently, reduced, regularly, remain, removing, repeatedly, restated, Riley, role, safety, serve, stimulation, sufficiency, supplement, supplemented, Technology, tolerability, transferred, transition, transport, tumor, uptake
Filing tables
Filing exhibits
HEPA similar filings
Filing view
External links
EXHIBIT 32.1
CERTIFICATION OF CHIEF EXECUTIVE OFFICER
HEPION PHARMACEUTICALS, INC.
FORM 10-Q FOR THE QUARTER ENDED MARCH 31, 2021
PURSUANT TO 18 U.S.C. SECTION 1350, AS ADOPTED
PURSUANT TO SECTION 906 OF THE SARBANES-OXLEY ACT OF 2002
I am the Chief Executive Officer of Hepion Pharmaceuticals, Inc., a Delaware corporation (the “Company”). I am delivering this certificate in connection with the Form 10-Q of the Company for the quarter ended March 31, 2021 and filed with the Securities and Exchange Commission (“Form 10-Q”).
Pursuant to 18 U.S.C. Section 1350, as adopted pursuant to Section 906 of the Sarbanes-Oxley Act of 2002, I hereby certify that, to the best of my knowledge, the Form 10-Q fully complies with the requirements of Section 13(a) or Section 15(d) of the Securities Exchange Act of 1934 and that the information contained in the Form 10-Q fairly presents, in all material respects, the financial condition and results of operations of the Company.
Date: May 14, 2021 | /s/ Robert Foster | ||||
Robert Foster | |||||
Chief Executive Officer and Director | |||||
(Principal Executive Officer) |